EUDA / TheoremRx10 Oct 2023 09:44
All this excitement about the letter of intent for the above companies.
I was just looking at EUDA - they're pretty small in size - circa $40m Mkt Cap and then we have TheoremRx who seem to have a registered office in an apartment block in NY City.
It's hardly a Blockbuster deal if it went through.
Also, we signed a letter of intent in Sep 21 - nothing has happened since has it?
With Biotech on the push right now, and talk of the market awash with cash for deals, why can't our partners get it away?
Why do Euda and TheoremRx want to merge in the first place?